CA2250714C - Cellules animales et procedes de replication des virus de la grippe - Google Patents

Cellules animales et procedes de replication des virus de la grippe Download PDF

Info

Publication number: CA2250714C
Authority: CA; Canada
Prior art keywords: cells; cell; infection; influenza viruses; mdck
Prior art date: 1996-04-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA002250714A

Other languages

English (en)

Other versions

CA2250714A1 (fr

Inventor

Albrecht Groner

Jurgen Vorlop

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Novartis AG

Chiron Behring GmbH and Co KG

Novartis Vaccines and Diagnostics GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-01

Filing date

1997-04-01

Publication date

2006-08-01

1996-04-01 Priority claimed from DE19612966A external-priority patent/DE19612966B4/de

1997-04-01 Application filed by Novartis AG, Chiron Behring GmbH and Co KG, Novartis Vaccines and Diagnostics GmbH filed Critical Novartis AG

1997-10-09 Publication of CA2250714A1 publication Critical patent/CA2250714A1/fr

2006-08-01 Application granted granted Critical

2006-08-01 Publication of CA2250714C publication Critical patent/CA2250714C/fr

2017-04-01 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

241000712461 unidentified influenza virus Species 0.000 title claims abstract description 70
238000000034 method Methods 0.000 title claims abstract description 59
230000010076 replication Effects 0.000 title claims abstract description 28
210000004102 animal cell Anatomy 0.000 title abstract description 5
238000004113 cell culture Methods 0.000 claims abstract description 50
239000000725 suspension Substances 0.000 claims abstract description 15
239000012679 serum free medium Substances 0.000 claims abstract description 10
208000015181 infectious disease Diseases 0.000 claims description 58
241000700605 Viruses Species 0.000 claims description 46
230000010412 perfusion Effects 0.000 claims description 25
102000004142 Trypsin Human genes 0.000 claims description 22
108090000631 Trypsin Proteins 0.000 claims description 22
239000012588 trypsin Substances 0.000 claims description 22
108091005804 Peptidases Proteins 0.000 claims description 14
239000004365 Protease Substances 0.000 claims description 14
239000001963 growth medium Substances 0.000 claims description 8
238000003306 harvesting Methods 0.000 claims description 8
101710154606 Hemagglutinin Proteins 0.000 claims description 7
101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 7
101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 7
101710176177 Protein A56 Proteins 0.000 claims description 7
239000000185 hemagglutinin Substances 0.000 claims description 7
238000002955 isolation Methods 0.000 claims description 7
238000010923 batch production Methods 0.000 claims description 6
102000004169 proteins and genes Human genes 0.000 claims description 6
108090000623 proteins and genes Proteins 0.000 claims description 6
239000006285 cell suspension Substances 0.000 claims description 5
102000012479 Serine Proteases Human genes 0.000 claims description 4
108010022999 Serine Proteases Proteins 0.000 claims description 4
239000002243 precursor Substances 0.000 claims description 3
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 5
230000002062 proliferating effect Effects 0.000 claims 1
210000004027 cell Anatomy 0.000 abstract description 154
229960005486 vaccine Drugs 0.000 abstract description 32
239000000470 constituent Substances 0.000 abstract description 7
239000002609 medium Substances 0.000 description 37
230000029812 viral genome replication Effects 0.000 description 24
239000000427 antigen Substances 0.000 description 21
102000036639 antigens Human genes 0.000 description 21
108091007433 antigens Proteins 0.000 description 21
238000007792 addition Methods 0.000 description 20
235000013601 eggs Nutrition 0.000 description 13
238000002474 experimental method Methods 0.000 description 10
102000035195 Peptidases Human genes 0.000 description 9
238000012258 culturing Methods 0.000 description 9
230000001105 regulatory effect Effects 0.000 description 9
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
239000012141 concentrate Substances 0.000 description 7
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
239000008103 glucose Substances 0.000 description 6
206010022000 influenza Diseases 0.000 description 6
230000003472 neutralizing effect Effects 0.000 description 6
238000001914 filtration Methods 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
235000018102 proteins Nutrition 0.000 description 5
230000003442 weekly effect Effects 0.000 description 5
239000006143 cell culture medium Substances 0.000 description 4
238000011534 incubation Methods 0.000 description 4
208000037797 influenza A Diseases 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
241001465754 Metazoa Species 0.000 description 3
241000282898 Sus scrofa Species 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
230000004663 cell proliferation Effects 0.000 description 3
238000011109 contamination Methods 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
239000012530 fluid Substances 0.000 description 3
244000005700 microbiome Species 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000002245 particle Substances 0.000 description 3
238000012770 revaccination Methods 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
239000000243 solution Substances 0.000 description 3
239000011550 stock solution Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
ZGNLFUXWZJGETL-YUSKDDKASA-N (Z)-[(2S)-2-amino-2-carboxyethyl]-hydroxyimino-oxidoazanium Chemical compound N[C@@H](C\[N+]([O-])=N\O)C(O)=O ZGNLFUXWZJGETL-YUSKDDKASA-N 0.000 description 2
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 2
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
241001500351 Influenzavirus A Species 0.000 description 2
MLFKVJCWGUZWNV-UHFFFAOYSA-N L-alanosine Natural products OC(=O)C(N)CN(O)N=O MLFKVJCWGUZWNV-UHFFFAOYSA-N 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
241000845082 Panama Species 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
239000000654 additive Substances 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
229950005033 alanosine Drugs 0.000 description 2
229960003896 aminopterin Drugs 0.000 description 2
230000002238 attenuated effect Effects 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
238000009295 crossflow filtration Methods 0.000 description 2
239000012228 culture supernatant Substances 0.000 description 2
230000008021 deposition Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000003599 detergent Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
210000002257 embryonic structure Anatomy 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
238000009472 formulation Methods 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
230000003067 hemagglutinative effect Effects 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
230000001524 infective effect Effects 0.000 description 2
229960003971 influenza vaccine Drugs 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
210000001161 mammalian embryo Anatomy 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000007017 scission Effects 0.000 description 2
239000004017 serum-free culture medium Substances 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
229940031626 subunit vaccine Drugs 0.000 description 2
241000271566 Aves Species 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
108010076119 Caseins Proteins 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
241000991587 Enterovirus C Species 0.000 description 1
101001064282 Homo sapiens Platelet-activating factor acetylhydrolase IB subunit beta Proteins 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
208000005647 Mumps Diseases 0.000 description 1
238000011785 NMRI mouse Methods 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102100030655 Platelet-activating factor acetylhydrolase IB subunit beta Human genes 0.000 description 1
241000711798 Rabies lyssavirus Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
238000005273 aeration Methods 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
229940031567 attenuated vaccine Drugs 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000005018 casein Substances 0.000 description 1
108010079058 casein hydrolysate Proteins 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
238000010370 cell cloning Methods 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
230000001955 cumulated effect Effects 0.000 description 1
230000000120 cytopathologic effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
244000144992 flock Species 0.000 description 1
239000008098 formaldehyde solution Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000000413 hydrolysate Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
229940031551 inactivated vaccine Drugs 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
231100000636 lethal dose Toxicity 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000011068 loading method Methods 0.000 description 1
238000000464 low-speed centrifugation Methods 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000000463 material Substances 0.000 description 1
239000002184 metal Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
208000010805 mumps infectious disease Diseases 0.000 description 1
239000003921 oil Substances 0.000 description 1
229960005030 other vaccine in atc Drugs 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
238000000053 physical method Methods 0.000 description 1
239000011148 porous material Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000013630 prepared media Substances 0.000 description 1
239000002510 pyrogen Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000029219 regulation of pH Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
201000005404 rubella Diseases 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
235000017709 saponins Nutrition 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000002904 solvent Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000000856 sucrose gradient centrifugation Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000004114 suspension culture Methods 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
229940075420 xanthine Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Pulmonology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

CA002250714A 1996-04-01 1997-04-01 Cellules animales et procedes de replication des virus de la grippe Expired - Lifetime CA2250714C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19612966A DE19612966B4 (de)	1996-04-01	1996-04-01	MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612966.4		1996-04-01
PCT/IB1997/000403 WO1997037000A1 (fr)	1996-04-01	1997-04-01	Cellules animales et procedes de replication des virus de la grippe

Publications (2)

Publication Number	Publication Date
CA2250714A1 CA2250714A1 (fr)	1997-10-09
CA2250714C true CA2250714C (fr)	2006-08-01

Family

ID=36764354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002250714A Expired - Lifetime CA2250714C (fr)	1996-04-01	1997-04-01	Cellules animales et procedes de replication des virus de la grippe

Country Status (1)

Country	Link
CA (1)	CA2250714C (fr)

1997
- 1997-04-01 CA CA002250714A patent/CA2250714C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2250714A1 (fr)	1997-10-09

Legal Events

Date	Code	Title	Description
2001-10-30	EEER	Examination request

Publication	Publication Date	Title
US6656720B2 (en)	2003-12-02	Animal cells and processes for the replication of influenza viruses
EP0891420B1 (fr)	2005-02-02	Procedes de replication des virus de la grippe dans une culture cellulaire, et virus de la grippe obtenus selon ce procede
FI121117B (fi)	2010-07-15	Menetelmä biologisten tuotteiden tuottamiseksi proteiinittomassa viljelmässä
RU2457253C2 (ru)	2012-07-27	Способ репликации вируса в птичьих эмбриональных стволовых клетках
HRP980187A2 (en)	1999-04-30	Influenza vaccine
HK1152546A (en)	2012-03-02	Animal cells and processes for the replication of influenza viruses
HK1019233B (en)	2011-05-13	Animal cells and processes for the replication of influenza viruses
HK1075467B (en)	2012-04-05	Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
HK1142093B (en)	2014-08-01	Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process